---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-092676"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:29:08.399308+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nutriband receives Chinese patent for AVERSA abuse-deterrent transdermal system

## Summary
- CNIPA fully issued Patent No. ZL 202211158031 for 'Abuse and Misuse Deterrent Transdermal System' related to AVERSA technology.
- Patent covers taste aversion to prevent abuse of opioid patches; previously allowed in September 2024.
- AVERSA IP portfolio now includes granted patents in US, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
- Lead product under development is an abuse-deterrent fentanyl patch incorporating AVERSA technology.

## SEC filing metadata
- accession: 0001213900-24-092676
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390024092676/0001213900-24-092676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390024092676/ea0219429-8k_nutriband.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-092676
- JSON: https://secwatch.observer/filing/0001213900-24-092676.json
- Plain text: https://secwatch.observer/filing/0001213900-24-092676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.